Prevention of Acute Graft Rejection by the Prostaglandin E1Analogue Misoprostol in Renal-Transplant Recipients Treated with Cyclosporine and Prednisone
- 26 April 1990
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 322 (17), 1183-1188
- https://doi.org/10.1056/nejm199004263221703
Abstract
Prostaglandins of the E series have been shown to have immunosuppressive properties. To study the effects of the prostaglandin E1 analogue misoprostol on renal function and graft rejection after transplantation, we conducted a randomized, double-blind, placebo-controlled trial in 77 renal-allograft recipients.This publication has 26 references indexed in Scilit:
- Role of renal prostaglandins and the effects of nonsteroidal anti-inflammatory drugs in patients with liver diseaseAmerican Journal Of Medicine, 1986
- A Randomized Clinical Trial of Cyclosporine in Cadaveric Renal TransplantationNew England Journal of Medicine, 1986
- Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal functionAmerican Journal Of Medicine, 1985
- Effects of Sulindac and Ibuprofen in Patients with Chronic Glomerular DiseaseNew England Journal of Medicine, 1984
- CYCLOSPORIN IN CADAVERIC RENAL TRANSPLANTATION: ONE-YEAR FOLLOW-UP OF A MULTICENTRE TRIALThe Lancet, 1983
- PROSTAGLANDIN AS AN EFFECTIVE ANTIREJECTION THERAPY IN RAT RENAL ALLOGRAFT RECIPIENTSTransplantation, 1983
- Arachidonic acid metabolism, prostaglandins and the kidneyThe American Journal of Medicine, 1982
- Prostaglandins, Renal Function and Vascular RegulationMedical Clinics of North America, 1981
- CYCLOSPORIN A INITIALLY AS THE ONLY IMMUNOSUPPRESSANT IN 34 RECIPIENTS OF CADAVERIC ORGANS: 32 KIDNEYS, 2 PANCREASES, AND 2 LIVERSThe Lancet, 1979
- Prostaglandins and the KidneyCirculation Research, 1973